Aneal is a Partner, Associate Portfolio Manager for Sofinnova BioEquities. He focuses primarily on public investments in global biotechnology, pharmaceutical and medical technology companies. He has over a decade of experience in public, healthcare investing.
Prior to joining Sofinnova in 2019, Aneal was a Senior Analyst at Citadel for five years where he helped manage a healthcare-focused portfolio. Before Citadel, Aneal was an Analyst at Point72 covering healthcare investments. Before public investing, Aneal was an Investment Banker at Greenhill where he focused on healthcare M&A.
Aneal received his M.S. in Biotechnology from Johns Hopkins and B.B.A. from the University of Texas-Austin where he graduated with high honors.